Methotrexate Treatment of Ectopic Pregnancy: Observations on the Medical Literature

American College of Obstetricians, and Gynecologists Medical Management of Tubal Pregnancy Practice Bulletin No. 3 Washington, DC. Dec, 1998.

Barnhart K. ; Esposito M. : Coutiforis C. “An Update on the Medical Treatment of Ectopic Pregnancy.” Obst. & Gyn. Clinics – Current Reproductive Endocrinology 27(3): 2000.

Catechism of the Catholic Church 2nd Ed. U.S. Catholic Conference. Inc. - Libreria Editrice Vaticana. 1994.

Clark P.A. “Methotrexate and Tubal Pregnancies: Direct or Indirect Abortion?” The Linacre Quarterly 67(1): 7–24. 2000.

Corr R.J. , & Evans P. “Ectopic Pregnancy.” Primary Care: Clinics in Office Practice, Update in Maternity Care 27(1): 2000.

Creinin M.D. “Medical Abortion Regimens: Historical Context and Overview.” American Journal of Obstetrics and Gynecology 183(2): S3–S9 (Early Medical Abortion), 2000.

Creinin M.D. ; Stewart-Akers A.M. ; DeLoia J.A. “Methotrexate Effects on Trophoblast and Corpus Luteum in Early Pregnancy.” American Journal of Obstetrics and Gynecology 179(3): 1998.

Creinin M.D. “Medical Abortion with Methotrexate 75 mg Intramuscularly and Vaginal Misoprostol.” Contraception 56(6): 376–71. 1997.

Debby A. “Fertility Outcome Following Combined Methotrexate Treatment of Unruptured Extrauterine Pregnancy” British Journal of Obstetrics and Gynecology 107(5): 626–30, 2000.

Gabbe Obstetrics — Normal and Problem Pregnancies 3rd Ed. Churchill — Livingstone, 1996.

Gherman R.B. ; Stitely M. ; Larrimore C ; Nevin K. ; Coppola A. ; Weise D. “Low Dose Methotrexate Treatment for Interstitial Pregnancy: A case report.” J. Reproductive Medicine 45(2): 142–4, 2000.

Hajenius P.J. ; Mol B.W. : Bossuyt P.M. , Ankum W.M. , Van der Veen F. “Interventions for Tubal Ectopic Pregnancy.” Cochrane Database of Systematic Reviews, 2000.

Hajenius P.J. ; Engelsbel S. ; Mol B.W. ; Van der Veen F. ; Ankum W.M. ; Bossuyt P.M. ; Hemrika D.J. ; Lammes F.B. “Randomized Trial of Systemic Methotrexate Versus Laparoscopic Salpingostomy in Tubal Pregnancy.” Lancet 350: 774–9, 1997.

Keefe K.A. ; Wald J.S. ; Goldstein D.P. ; Bernstein M. ; Berkowitz R.S. “Reproductive Outcome after Methotrexate Treatment of Tubal Pregnancies.” J. Reproductive Medicine 43(1): 28–32, 1998.

Kim H.H. , & Fox J.H. “The Fallopian Tube and Ectopic Pregnancy (Chapter 8)” In Ryan: Kistner's Gynecology and Women's Health 7th Ed. Mosby, Inc. 1999.

Lipscomb G.H. ; Bran D. ; McCord M.L. ; Portera J.C. ; Ling F.W. “Analysis of Three Hundred Fifteen Ectopic Pregnancies Treated with Single Dose Methotrexate.” American Journal of Obstetrics and Gynecology 178(6): 1998.

Lipscomb G.H. ; McCord M.L. ; Stovall T.G. ; Huff G. ; Portera S.G. ; Ling F.W. “Predictors of Success of Methotrexate Treatment in Women with Tubal Ectopic Pregnancies.” New England Journal of Medicine 341(26): 1974–8, 1999.

May W.E. “Abortion and Human Life (Ch. 5)”. Catholic Bioethics and the Gift of Human Life Our Sunday Visitor Publishing Div., OSV Inc. 2000

Mol B.W. ; Hajenius P.J. ; Engelsbel S. ; Ankum W.M. ; Hemrika D.J. ; Van der Venn F. ; Bossuyt P.M. “Treatment of Tubal Pregnancy in the Netherlands: An Economic Comparison of Systemic Methotrexate Administration and Laparoscopic Salpingostomy.” American Journal of Obstetrics and Gynecology 181(4): 945–51, 1999.

Morlock R.J. ; Lafata J.E. ; Eisenstein D. “Cost Effectiveness of Single Dose Methotrexate Compared with Laparoscopic Treatment of Ectopic Pregnancy.” Obstetrics and Gynecology 95(3): 407–12. 2000.

National Conference of Catholic Bishops, Ethical and Religious Directives for Catholic Health Care Facilities (Washington, DC, NCCB, 1971) No. 16.

National Conference of Catholic Bishops, Ethical and Religious Directives for Catholic Health Care Facilities (Washington, DC, NCCB, 1994) No. 48.

Perdu M. ; Camus E. ; Rozenberg P. : Gaffinet F. ; Chastang C. ; Phillippe H.-J. : Nisand I. “Treating Ectopic Pregnancy with the Combination of Mifepristone and Methotrexate: A Phase II Non-Randomized Study.” American Journal of Obstetrics and Gynecology 179(3): 1998.

Pymar H.C. ; Creinin M.D. “Alternatives to Mifepristone Regimens for Medical Abortion.” American Journal of Obstetrics and Gynecology 183(2): S54–S64 (Early Medical Abortion), 2000.

Schatz F ; Papp C ; Aigner S. ; Krikun G. ; Hausnecht V. ; Lockwood C.J. “Biological Mechanisms Underlying the Clinical Effects of RU 486: Modulation of Cultured Endometrial Stromal Cell Stromelysin-1 and Prolactin Expression.” Journal of Clinical Endocrinology and Metabolism 82(1): 1997.

Sefer D.B. ; Gutmann J.N. ; Doyle M.B. ; Jones E.E. ; Diamond M.P. ; DeCherney A.H. “Persistent Ectopic Pregnancy Following Laparoscopic Linear Salpingostomy.” Obstetrics and Gynecology 17: 1089–94. 1988.

Stika C.S. : Anderson L. ; Frederiken M.C. “Single Dose Methotrexate for the Treatment of Ectopic Pregnancy: Northwestern Memorial Hospital Three Year Experience” American Journal of Obstetrics and Gynecology 1746), 1996.

Stoval T.G. , Ling F.W. ; Gray L.A. : Carson S.A. : Buster D.E. “Methotrexate Treatment of Unruptured Ectopic Pregnancy: A Report of 100 Cases.” Obstetrics and Gynecology 77: 749–53; 1991.

Stoval T.G. , & Ling F.W. “Single Dose Methotrexate: An Expanded Clinical Trial.” American Journal of Obstetrics and Gynecology 168: 1759–65, 1993.

Vermesh M. ; Silva P.D. ; Rosen G. F. ; Stein A.L. ; Fossum G.T. ; Sauer M.V. “Management of Unruptured Ectopic Gestation by Linear Salpingostomy: A Prospective, Randomized, Clinical Trial of Laparoscopy Versus Laparotomy.” Obstetrics and Gynecology 73: 400–4, 1989.